161 related articles for article (PubMed ID: 19523975)
1. The Pro/Pro genotype of the p53 codon 72 polymorphism modulates PAI-1 plasma levels in ageing.
Testa R; Bonfigli AR; Salvioli S; Invidia L; Pierini M; Sirolla C; Marra M; Testa I; Fazioli F; Recchioni R; Marcheselli F; Olivieri F; Lanari L; Franceschi C
Mech Ageing Dev; 2009 Aug; 130(8):497-500. PubMed ID: 19523975
[TBL] [Abstract][Full Text] [Related]
2. The different apoptotic potential of the p53 codon 72 alleles increases with age and modulates in vivo ischaemia-induced cell death.
Bonafé M; Salvioli S; Barbi C; Trapassi C; Tocco F; Storci G; Invidia L; Vannini I; Rossi M; Marzi E; Mishto M; Capri M; Olivieri F; Antonicelli R; Memo M; Uberti D; Nacmias B; Sorbi S; Monti D; Franceschi C
Cell Death Differ; 2004 Sep; 11(9):962-73. PubMed ID: 15131588
[TBL] [Abstract][Full Text] [Related]
3. Proline homozygosity in codon 72 of TP53 is a factor of susceptibility to nasopharyngeal carcinoma in Tunisia.
Hadhri-Guiga B; Toumi N; Khabir A; Sellami-Boudawara T; Ghorbel A; Daoud J; Frikha M; Gargouri A; Mokdad-Gargouri R
Cancer Genet Cytogenet; 2007 Oct; 178(2):89-93. PubMed ID: 17954263
[TBL] [Abstract][Full Text] [Related]
4. The p53 codon 72 proline allele is associated with p53 gene mutations in non-small cell lung cancer.
Hu Y; McDermott MP; Ahrendt SA
Clin Cancer Res; 2005 Apr; 11(7):2502-9. PubMed ID: 15814626
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein is directly related to plasminogen activator inhibitor type 1 (PAI-1) levels in diabetic subjects with the 4G allele at position -675 of the PAI-1 gene.
Testa R; Bonfigli AR; Sirolla C; Marra M; Boemi M; Mari D; Sacchi E; Dolci A; Catalano A; Procopio A; Ceriello A
Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):220-6. PubMed ID: 17433639
[TBL] [Abstract][Full Text] [Related]
6. Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer.
Granja F; Morari J; Morari EC; Correa LA; Assumpção LV; Ward LS
Cancer Lett; 2004 Jul; 210(2):151-7. PubMed ID: 15183530
[TBL] [Abstract][Full Text] [Related]
7. Homozygous proline at codon 72 of p53 as a potential risk factor favoring the development of undifferentiated thyroid carcinoma.
Boltze C; Roessner A; Landt O; Szibor R; Peters B; Schneider-Stock R
Int J Oncol; 2002 Nov; 21(5):1151-4. PubMed ID: 12370767
[TBL] [Abstract][Full Text] [Related]
8. Association between the TP53 codon72 polymorphism and oral cancer risk and prognosis.
Kuroda Y; Nakao H; Ikemura K; Katoh T
Oral Oncol; 2007 Nov; 43(10):1043-8. PubMed ID: 17306604
[TBL] [Abstract][Full Text] [Related]
9. p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never-smokers.
Ji X; Neumann AS; Sturgis EM; Adler-Storthz K; Dahlstrom KR; Schiller JT; Wei Q; Li G
Carcinogenesis; 2008 Apr; 29(4):875-9. PubMed ID: 18258602
[TBL] [Abstract][Full Text] [Related]
10. TP53 codon 72 polymorphism contributes to nasopharyngeal cancer susceptibility: a meta-analysis.
Zhuo XL; Cai L; Xiang ZL; Zhuo WL; Wang Y; Zhang XY
Arch Med Res; 2009 May; 40(4):299-305. PubMed ID: 19608020
[TBL] [Abstract][Full Text] [Related]
11. Influence of the TP53 codon 72 polymorphism on the cellular responses to X-irradiation in fibroblasts from nonagenarians.
den Reijer PM; Maier AB; Westendorp RG; van Heemst D
Mech Ageing Dev; 2008 Apr; 129(4):175-82. PubMed ID: 18272203
[TBL] [Abstract][Full Text] [Related]
12. [Correlation analysis between clinical phenotypes of keloids and polymorphism of p53 gene codon 72].
Liu Y; Gao J; Liu X; Lu F; Liu H
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Dec; 22(12):1433-6. PubMed ID: 19137883
[TBL] [Abstract][Full Text] [Related]
13. Polymorphism of p53 gene codon 72 in Kuwaiti with coronary artery disease and diabetes.
Alkhalaf M; Al-Bustan S; Hamoda H; Abdella N
Int J Cardiol; 2007 Jan; 115(1):1-6. PubMed ID: 16797751
[TBL] [Abstract][Full Text] [Related]
14. The -675 4G/5G polymorphism at the Plasminogen Activator Inhibitor 1 (PAI-1) gene modulates plasma Plasminogen Activator Inhibitor 1 concentrations in response to dietary fat consumption.
Pérez-Martínez P; Adarraga-Cansino MD; Fernández de la Puebla RA; Blanco-Molina A; Delgado-Lista J; Marín C; Ordovás JM; López-Miranda J; Pérez-Jiménez F
Br J Nutr; 2008 Apr; 99(4):699-702. PubMed ID: 17903340
[TBL] [Abstract][Full Text] [Related]
15. Evidence for an association of TP53 codon 72 polymorphism with breast cancer risk.
Damin AP; Frazzon AP; Damin DC; Roehe A; Hermes V; Zettler C; Alexandre CO
Cancer Detect Prev; 2006; 30(6):523-9. PubMed ID: 17113725
[TBL] [Abstract][Full Text] [Related]
16. The associations of p53 overexpression with p53 codon 72 genetic polymorphism in esophageal cancer.
Lee JM; Shun CT; Wu MT; Chen YY; Yang SY; Hung HI; Chen JS; Hsu HH; Huang PM; Kuo SW; Lee YC
Mutat Res; 2006 Feb; 594(1-2):181-8. PubMed ID: 16318864
[TBL] [Abstract][Full Text] [Related]
17. Polymorphism of TP53 codon 72 showed no association with breast cancer in Iranian women.
Khadang B; Fattahi MJ; Talei A; Dehaghani AS; Ghaderi A
Cancer Genet Cytogenet; 2007 Feb; 173(1):38-42. PubMed ID: 17284368
[TBL] [Abstract][Full Text] [Related]
18. P53 tumor suppressor factor, plasminogen activator inhibitor, and vascular endothelial growth factor gene polymorphisms and recurrent implantation failure.
Goodman C; Jeyendran RS; Coulam CB
Fertil Steril; 2009 Aug; 92(2):494-8. PubMed ID: 18829023
[TBL] [Abstract][Full Text] [Related]
19. p53 codon 72 polymorphism, DNA damage and repair, and risk of non-melanoma skin cancer.
Bendesky A; Rosales A; Salazar AM; Sordo M; Peniche J; Ostrosky-Wegman P
Mutat Res; 2007 Jun; 619(1-2):38-44. PubMed ID: 17403527
[TBL] [Abstract][Full Text] [Related]
20. Association between TP53 gene ARG72PRO polymorphism and chromosome aberrations in human cancers.
Litviakov NV; Denisov EV; Takhauov RM; Karpov AB; Skobel'skaja EV; Vasil'eva EO; Goncharik OO; Ageeva AM; Mamonova NV; Mezheritskiy SA; Sevost'janova NV; Koshel AP
Mol Carcinog; 2010 Jun; 49(6):521-4. PubMed ID: 20512840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
